Peritoneovenous Shunt.
Malik TF, Anjum F.
2023 Jul 31. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–.
Coagulopathy post peritoneovenous shunt.
LeVeen HH, Ip M, Ahmed N, Hutto RB, LeVeen EG.
Ann Surg. 1987 Mar;205(3):305-11. doi: 10.1097/00000658-198703000-00015.
Peritoneovenous Shunt for Intractable Ascites in Children: A Series of 4 Cases.
Defert C, Marret JB, Lacaille F, Sissaoui S, Dupic L, Lardy H, Capito C, Chardot C.
J Pediatr Gastroenterol Nutr. 2021 Jul 1;73(1):e7-e10. doi: 10.1097/MPG.0000000000003131.
Peritoneovenous shunt (PVS) for malignant ascites. An analysis of outcome.
Smith DA, Weaver DW, Bouwman DL.
Am Surg. 1989 Jul;55(7):445-9.
The place of the peritoneovenous shunt in the treatment of ascites.
LeVeen EG, LeVeen HH.
ASAIO Trans. 1989 Apr-Jun;35(2):165-8. doi: 10.1097/00002480-198904000-00011.
The peritoneovenous shunt: expectations and reality.
Moskovitz M.
Am J Gastroenterol. 1990 Aug;85(8):917-29.
Radiologically Placed Peritoneovenous Shunt is an Acceptable Treatment Alternative for Refractory Ascites Due to End-Stage Liver Disease.
Bakhtiar M, Forde KA, Nadolski GJ, Soulen MC, Weinberg EM.
J Vasc Interv Radiol. 2021 Nov;32(11):1606-1614. doi: 10.1016/j.jvir.2021.08.003. Epub 2021 Aug 17.
The influence of a peritoneovenous shunt for cirrhotic and malignant intractable ascites on renal function.
Segawa T, Kato K, Kawashima K, Suzuki T, Ehara S.
Acta Radiol Open. 2018 Mar 26;7(3):2058460118764208. doi: 10.1177/2058460118764208. eCollection 2018 Mar.
Peritoneovenous shunt scintigraphy to assess shunt patency in patients with refractory ascites.
Senthil R, Sundaraiya S, Perumalla R, Rela M.
J Clin Exp Hepatol. 2013 Dec;3(4):347-50. doi: 10.1016/j.jceh.2013.05.012. Epub 2013 Jun 27.
Predictive Factors for Treatment Failure after Peritoneovenous Shunt for Hepatic Ascites.
Iida H, Aihara T, Ikuta S, Yamanaka N.
Am Surg. 2017 Nov 1;83(11):1289-1293.
